22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181446)

  • 40
    Haplo
    Score
  • 0
    Triplo
    Score

Region Facts

Region Name
22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181446)
Cytoband
22q11.21
Genomic Coordinates
GRCh37/hg19 chr22:20366424-20371500 NCBI Ensembl UCSC
GRCh38/hg38 chr22:18516557-18521633 NCBI Ensembl UCSC

Dosage Sensitivity Summary (Region)

Dosage ID:
ISCA-46530
Curation Status:
Complete
Issue Type:
Dosage Curation - Region
Description:
SVTYPE=DEL GENES=GGTLC3 COPY_GAIN=NA GNOMAD AF=0.134185001 ORIGIN=gnomad_v2.1_sv.sites (May 1, 2021) GNOMAD URL=https://gnomad.broadinstitute.org/variant/DEL_22_181446?dataset=gnomad_sv_r2_1
Breakpoint Type:
Variable
Haploinsufficiency:
Dosage Sensitivity Unlikely (40)
Triplosensitivity:
No Evidence for Triplosensitivity (0)
gnomAD Allele Frequency:
0.134185001
Last Evaluated:
08/03/2021

Haploinsufficiency (HI) Score Details

HI Score:
40
HI Evidence Strength:
Dosage Sensitivity Unlikely (Disclaimer)
HI Evidence Comments:
As part of an effort to identify genomic regions that are unlikely to be dosage sensitive, ClinGen queried the gnomAD structural variant (SV) v2.1 data set (PMID: 32461652) for variants meeting the following criteria: passed gnomAD quality filters, characterized as either a deletion or duplication, >1kb in size, includes at least one gene, and present at an allele frequency of >5% (with at least 2000 alleles tested). This region corresponds to a variant identified as meeting these criteria in gnomAD-SV v2.1; the gnomAD identifier for this variant is reflected in the title for reference. As of May 1st, 2021, there has been no reported relationship between the gene(s) included in this region and human disease. Given the high population frequency, this region has been classified as “dosage sensitivity unlikely.”

Triplosensitivity (TS) Score Details

TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)

Genomic View

Select assembly: (NC_000022.10) (NC_000022.11)